Vena A, Muñoz P, Padilla B, Valerio M, Sanchez MI, Puig-Asensio M, Fortun J, Fernandez-Ruiz M, Merino P, Losa JE, Loza A, Rivas RA, Bouza E, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

Is routine ophthalmoscopy really necessary in candidemic patients?

Plos One 2017. 12(10): . Nº de citas: 26

[doi:10.1371/journal.pone.0183485]

Asmuth DM, Thompson CG, Chun TW, Ma ZM, Mann S, Sainz T, Serrano-Villar S, Utay NS, Garcia JC, Troia-Cancio P, Pollard RB, Miller CJ, Landay A, Kashuba AD.

Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.

JOURNAL OF INFECTIOUS DISEASES 2017. 216(7): 813-818. Nº de citas: 9

[doi:10.1093/infdis/jix418]

Norman FF, López-Polín A, Salvador F, Treviño B, Calabuig E, Torrús D, Soriano-Arandes A, Ruíz-Giardín JM, Monge-Maillo B, Pérez-Molina JA, Perez-Ayala A, García M, Rodríguez A, Martínez-Serrano M, Zubero M, López-Vélez R.

Imported malaria in Spain (2009-2016): results from the +REDIVI Collaborative Network.

MALARIA JOURNAL 2017. 16(1): 407-407. Nº de citas: 18

[doi:10.1186/s12936-017-2057-8]

Sánchez-Del Cojo M, López-Huertas MR, Díez-Fuertes F, Rodríguez-Mora S, Bermejo M, López-Campos G, Mateos E, Jiménez-Tormo L, Gómez-Esquer F, Díaz-Gil G, Alcamí J, Coiras M.

Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells.

Plos One 2017. 12(10): . Nº de citas: 13

[doi:10.1371/journal.pone.0185677]

Ghosn J, Bayan T, Meixenberger K, Tran L, Frange P, d'Arminio Monforte A, Zangerle R, de Mendoza C, Krastinova E, Porter K, Meyer L, Chaix ML, CASCADE Collaboration in EuroCoord.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2017. 72(10): 2862-2868. Nº de citas: 3

[doi:10.1093/jac/dkx247]

San-Juan R, Pérez-Montarelo D, Viedma E, Lalueza A, Fortún J, Loza E, Pujol M, Ardanuy C, Morales I, de Cueto M, Resino-Foz E, Morales-Cartagena MA, Fernández-Ruiz M, Rico A, Romero MP, Fernández de Mera M, López-Medrano F, Orellana MÁ, Aguado JM, Chaves F.

Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2017. 36(10): 1757-1765. Nº de citas: 8

[doi:10.1007/s10096-017-2989-5]

Crespo M, Navarro J, Moreno S, Sanz J, Márquez M, Zamora J, Ocampo A, Iribaren JA, Rivero A, Llibre JM.

Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2017. 35(8): 493-498. Nº de citas: 2

[doi:10.1016/j.eimc.2016.02.029]

Masiá M, Padilla S, Moreno S, Barber X, Iribarren JA, Del Romero J, Gómez-Sirvent JL, Rivero M, Vidal F, Campins AA, Gutiérrez F.

Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach.

Plos One 2017. 12(9): . Nº de citas: 5

[doi:10.1371/journal.pone.0184329]

Geretti AM, Loutfy M, D'Arminio Monforte A, Latysheva I, Pérez Elías MJ, Rymer J, Boffito M.

Out of focus: tailoring the cascade of care to the needs of women living with HIV.

HIV MEDICINE 2017. 18 Suppl 2: 3-17. Nº de citas: 7

[doi:10.1111/hiv.12533]

Vivancos MJ, Gómez-Ayerbe C, Moreno S.

Highlights in HIV, 2016.

REVISTA ESPANOLA DE QUIMIOTERAPIA 2017. 30 Suppl 1: 13-15.

Fortún J, Gioia F.

Invasive candidiasis in the neutropenic patient.

REVISTA ESPANOLA DE QUIMIOTERAPIA 2017. 30 Suppl 1: 22-25. Nº de citas: 4

Alpern JD, Lopez-Velez R, Stauffer WM.

Access to benznidazole for Chagas disease in the United States-Cautious optimism?

PLOS NEGLECTED TROPICAL DISEASES 2017. 11(9): . Nº de citas: 17

[doi:10.1371/journal.pntd.0005794]

Pérez-Molina JA, López-Polín A, Treviño B, Molina I, Goikoetxea J, Díaz-Menéndez M, Torrús D, Calabuig E, Benito A, López-Vélez R.

6-year review of +Redivi: a prospective registry of imported infectious diseases in Spain.

JOURNAL OF TRAVEL MEDICINE 2017. 24(5): . Nº de citas: 28

[doi:10.1093/jtm/tax035]

Moreno Guillen S, Losa García JE, Berenguer Berenguer J, Martínez Sesmero JM, Cenoz Gomis S, Graefenhain R, Lopez Sanchez-Cambronero D, Parrondo Garcia FJ.

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain.

FARMACIA HOSPITALARIA 2017. 41(5): 601-610.

[doi:10.7399/fh.10808]

Sanchez Conde M, Vivancos Gallego MJ, Moreno Guillen S.

Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties.

FARMACIA HOSPITALARIA 2017. 41(5): 630-637.

[doi:10.7399/fh.10821]

Fernández-Ruiz M, Guinea J, Lora-Pablos D, Zaragoza Ó, Puig-Asensio M, Almirante B, Cuenca-Estrella M, Aguado JM, CANDIPOP Project, GEIH-GEMICOMED (SEIMC) and REIPI.

Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.

CLINICAL MICROBIOLOGY AND INFECTION 2017. 23(9): . Nº de citas: 18

[doi:10.1016/j.cmi.2017.01.014]

Serrano-Villar S, Vázquez-Castellanos JF, Vallejo A, Latorre A, Sainz T, Ferrando-Martínez S, Rojo D, Martínez-Botas J, Del Romero J, Madrid N, Leal M, Mosele JI, Motilva MJ, Barbas C, Ferrer M, Moya A, Moreno S, Gosalbes MJ, Estrada V.

The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.

MUCOSAL IMMUNOLOGY 2017. 10(5): 1279-1293. Nº de citas: 61

[doi:10.1038/mi.2016.122]

Navarro M, Monge-Maíllo B, Flores-Chavez MD, López-Vélez R.

Hunting hidden parasites: Trypanosoma cruzi.

LANCET 2017. 390(10096): 724-726. Nº de citas: 12

[doi:10.1016/S0140-6736(17)31536-2]